Seleccionar página
Setmelanotide in patients aged 2–5 years

Setmelanotide in patients aged 2–5 years

Background Setmelanotide, a melanocortin-4 receptor (MC4R) agonist, has been shown to reduce hunger and weight in patients aged 6 years and older with proopiomelanocortin (POMC) deficiency (including biallelic variants in proprotein convertase subtilisin/kexin type 1...